Molecular imaging of the kidneys

Seminars in Nuclear Medicine

Volumn 41, Issue 1, 2011, Pages 20-28

  Szabo, Zsolt ^a   Alachkar, Nada ^b   Xia, Jinsong ^a   Mathews, William B ^a   Rabb, Hamid ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; CARBON 11; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE IX I 124; COPPER 64; ETHYLGLYOXALBIS(THIOSEMICARBAZONE) COPPER 64; FLUORODEOXYGLUCOSE F 18; IODINE 124; KIDNEY INJURY MOLECULE 1; MERTIATIDE TC 99M; MONOCLONAL ANTIBODY 1 AMINO 3 FLUOROCYCLOBUTANE 1 CARBOXYLIC ACID F 18; MONOCYTE CHEMOTACTIC PROTEIN 1; ORGANIC ANION TRANSPORTER; RADIOISOTOPE; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; RUBIDIUM 82; RUBIDIUM CHLORIDE RB 82; UNCLASSIFIED DRUG; WATER O 15;

AGING; ATHEROSCLEROSIS; BLOOD FLOWMETRY; CANCER DIAGNOSIS; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG HALF LIFE; DRUG UPTAKE; EARLY DIAGNOSIS; HUMAN; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY CANCER; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY PERFUSION; MOLECULAR IMAGING; MORBIDITY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; RADIOIMMUNOLOGY; RADIOIMMUNOTHERAPY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SCINTILLATION CAMERA;

ANIMALS; HUMANS; KIDNEY; KIDNEY NEOPLASMS; KIDNEY TUBULES; MOLECULAR IMAGING; REGIONAL BLOOD FLOW;

EID: 78649398319     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2010.09.003     Document Type: Review

References (67)

1. G. Glimstedt Some recent views on the structure and function of the kidney Bull Schweiz Akad MED Wiss 3 1947 182 195
2. F.O. Drenckhahn, and J. Meissner Autoradiographic studies on the localization of S35 labelled Na2SO4 in the kidney of Guinea pigs Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 227 1956 444 455
3. K. zum Winkel, and K.E. Scheer Principles of kidney scintigraphy with Hg-203 labelled Salyrgan Nucl Med (Stuttg) 2 1961 71 79
4. D.L. Tabern, J. Kearney, and H. Sohn The quantitative measurement of tubular chlormerodrin binding as an index of renal function: a study of 400 cases CMAJ 103 1970 601 607
5. R.C. Stadalnik, J.M. Vogel, and A.L. Jansholt Renal clearance and extraction parameters of ortho-iodohippurate (I-123) compared with OIH(I-131) and PAH J Nucl Med 21 1980 168 170
6. L. Juillard, M.F. Janier, and D. Fouque Renal blood flow measurement by positron emission tomography using 15O-labeled water Kidney Int 57 2000 2511 2518
7. N.M. Alpert, C.A. Rabito, and D.J. Correia Mapping of local renal blood flow with PET and H(2) 15O J Nucl Med 43 2002 470 475
8. E. Lebowitz, and P. Richards Radionuclide generator systems Semin Nucl Med 4 1974 257 268
9. N. Tamaki, C.A. Rabito, and N.M. Alpert Serial analysis of renal blood flow by positron tomography with rubidium-82 Am J Physiol 251 1986 H1024 H1030
10. O. Andrysek, O. Schuck, and J. Andryskova Macro-radio-autographic localization of bromine-82, rubidium-86 and phosphorous-32 in the canine kidney Nature 193 1962 283 284
11. M.A. Green, C.J. Mathias, and L.R. Willis Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion Nucl Med Biol 34 2007 247 255
12. R. Taugner, E. Hackenthal, and U. Helmchen The intrarenal renin-angiotensin-system An immunocytochemical study on the localization of renin, angiotensinogen, converting enzyme and the angiotensins in the kidney of mouse and rat Klin Wochenschr 60 1982 1218 1222
13. K. Song, J. Zhuo, and S.Y. Chai A new method to localize active renin in tissues by autoradiography: application to dog kidney Kidney Int 42 1992 639 646
14. J. Peti-Peterdi, J.J. Kang, and I. Toma Activation of the renal renin-angiotensin system in diabetesnew concepts Nephrol Dial Transplant 23 2008 3047 3049
15. E.J. Fine, and Z. Szabo Vascular disorders, with emphasis on hypertension P.J. Ell, S.S. Gambhir, Nuclear Medicine in Clinical Diagnosis and Treatment 2004 Churchill Livingstone Edinburgh 1601-1524
16. J. Xia, E. Seckin, and Y. Xiang Positron-emission tomography imaging of the angiotensin II subtype 1 receptor in swine renal artery stenosis Hypertension 51 2008 466 473
17. N. Shikano, Y. Kanai, and K. Kawai Transport of 99mTc-MAG3 via rat renal organic anion transporter 1 J Nucl Med 45 2004 80 85
18. R.A. Van Aubel, R. Masereeuw, and F.G. Russel Molecular pharmacology of renal organic anion transporters Am J Physiol Ren Physiol 279 2000 F216 F232
19. X. Sun, J. Kim, and A.E. Martell In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands Nucl Med Biol 31 2004 1051 1059
20. J. Yoo, D.E. Reichert, and J. Kim A potential DubinJohnson syndrome imaging agent: synthesis, biodistribution, and micropet imaging Mol Imaging 4 2005 18 29
21. J.L. McNay, S. Rosello, and P.G. Dayton Effects of azotemia on renal extraction and clearance of PAH and TEA Am J Physiol 230 1976 901 906
22. K.K. Solanki, J. Bomanji, and C.C. Nimmon Tc-99m labeled cationic complexesa new class of renal imaging agentsresults of preliminary human studies J Nucl Med 32 1991 1105
23. A.K. Padhy, K.K. Solanki, and J. Bomanji Clinical evaluation of 99mTc diaminocyclohexane, a renal tubular agent with cationic transport: results in healthy human volunteers Nephron 65 1993 294 298
24. C.D. Klaassen, and L.M. Aleksunes Xenobiotic, bile acid, and cholesterol transporters: function and regulation Pharmacol Rev 62 2010 1 96
25. N.B. Nabulsi, D.E. Smith, and M.R. Kilbourn [(11)C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type mice Bioorg Med Chem 13 2005 2993 3001
26. S. Nijjar, J. Patterson, and J. Ducharme The effect of furosemide dose timing on bladder activity in oncology imaging with 18F-fluorodeoxyglucose PET/CT Nucl Med Commun 31 2010 167 172
27. Z. Szabo, H. Vosberg, and C.A. Sondhaus Model identification and estimation of organ-function parameters using radioactive tracers and the impulse-response function Eur J Nucl Med 11 1985 265 274
28. R. Bouley, Z. Palomino, and S.S. Tang Angiotensin II and hypertonicity modulate proximal tubular aquaporin 1 expression Am J Physiol Ren Physiol 297 2009 F1575 F1586
29. K. Takata, T. Matsuzaki, and Y. Tajika Localization and trafficking of aquaporin 2 in the kidney Histochem Cell Biol 130 2008 197 209
30. P. Kannan, C. John, and S.S. Zoghbi Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications Clin Pharmacol Ther 86 2009 368 377
31. O. Marsenic Glucose control by the kidney: an emerging target in diabetes Am J Kidney Dis 53 2009 875 883
32. M. Kobayashi, N. Shikano, and R. Nishii Comparison of the transcellular transport of FDG and d-glucose by the kidney epithelial cell line, LLC-PK1 Nucl Med Commun 31 2010 141 146
33. T.J. de Groot, M. Veyhl, and C. Terwinghe Synthesis of 18F-fluoroalkyl-beta-D-glucosides and their evaluation as tracers for sodium-dependent glucose transporters J Nucl Med 44 2003 1973 1981 (Pubitemid 40022144)
34. W.K. Han, and J.V. Bonventre Biologic markers for the early detection of acute kidney injury Curr Opin Crit Care 10 2004 476 482
35. C.R. Parikh, J. Mishra, and H. Thiessen-Philbrook Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery Kidney Int 70 2006 199 203
36. T. Ichimura, and S. Mou Kidney injury molecule 1 in acute kidney injury and renal repair: a review Zhong Xi Yi Jie He Xue Bao 6 2008 533 538
37. T. Ichimura, E.J. Asseldonk, and B.D. Humphreys Kidney injury molecule 1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells J Clin Invest 118 2008 1657 1668
38. W.K. Han, A. Alinani, and C.L. Wu Human kidney injury molecule 1 is a tissue and urinary tumor marker of renal cell carcinoma J Am Soc Nephrol 16 2005 1126 1134
39. J. Mishra, K. Mori, and Q. Ma Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity Am J Nephrol 24 2004 307 315
40. M.K. Hanna Antenatal hydronephrosis and ureteropelvic junction obstruction: the case for early intervention Urology 55 2000 612 615
41. N. Holmes, M.R. Harrison, and L.S. Baskin Fetal surgery for posterior urethral valves: long-term postnatal outcomes Pediatrics 108 2001 E7
42. R.L. Chevalier Biomarkers of congenital obstructive nephropathy: past, present and future J Urol 172 2004 852 857
43. G. Grandaliano, L. Gesualdo, and F. Bartoli MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy Kidney Int 58 2000 182 192
44. C.F. Lynch, M.M. West, and J.A. Davila Cancers of the kidney and renal pelvis L.A.G. Ries, J.L. Young, G.E. Keel, SEER Survival Monograph: Cancer Survival Among Adults US SEER Program, 1988-2001, Patient and Tumor Characteristics., Pub NIH No. 07-6215 2007 National Cancer Institute, NIH Bethesda, MD 193 202
45. L.M. Hock, J. Lynch, and K.C. Balaji Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data J Urol 167 2002 57 60
46. P. Russo Partial nephrectomy for renal cancer Part I BJU Int 105 2010 1206 1220
47. R.L. Wahl, J. Harney, and G. Hutchins Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-fluoro-d-glucose: pilot animal and human studies J Urol 146 1991 1470 1474
48. T. Powles, I. Murray, and C. Brock Molecular positron emission tomography and PET/CT imaging in urological malignancies Eur Urol 51 2007 1511 1520
49. D.E. Kang, R.L. White Jr, and J.H. Zuger Clinical use of fluorodeoxyglucose F-18 positron emission tomography for detection of renal cell carcinoma J Urol 171 2004 1806 1809
50. N.S. Majhail, J.L. Urbain, and J.M. Albani F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma J Clin Oncol 21 2003 3995 4000
51. N. Lawrentschuk, A.M. Poon, and S.S. Foo Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography BJU Int 96 2005 540 546
52. P. Shreve, P.C. Chiao, and H.D. Humes Carbon-11-acetate PET imaging in renal disease J Nucl Med 36 1995 1595 1601
53. N. Oyama, H. Okazawa, and N. Kusukawa 11C-acetate PET imaging for renal cell carcinoma Eur J Nucl Med Mol Imaging 36 2009 422 427
54. J. Kotzerke, C. Linne, and M. Meinhardt [One-(11) C]acetate uptake is not increased in renal cell carcinoma Eur J Nucl Med Mol Imaging 34 2007 884 888
55. Y. Yoshii, A. Waki, and T. Furukawa Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET Nucl Med Biol 36 2009 771 777
56. M. Yun, S.H. Bang, and J.W. Kim The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma J Nucl Med 50 2009 1222 1228
57. A.L. Vavere, S.J. Kridel, and F.B. Wheeler 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer J Nucl Med 49 2008 327 334
58. D.M. Schuster, J.A. Nye, and P.T. Nieh Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[18F]FACBC) with PET in renal carcinoma Mol Imaging Biol 11 2009 434 438
59. T.M. Shoup, J. Olson, and J.M. Hoffman Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors J Nucl Med 40 1999 331 338
60. D.M. Schuster, J.R. Votaw, and P.T. Nieh Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma J Nucl Med 48 2007 56 63
61. C.R. Divgi, N. Pandit-Taskar, and A.A. Jungbluth Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial Lancet Oncol 8 2007 304 310
62. S. Chua, G. Gnanasegaran, and G.J. Cook Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases Semin Nucl Med 39 2009 416 430
63. A. Staudenherz, B. Steiner, and S. Puig Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma? Cancer 85 1999 153 155
64. H.C. Wu, R.F. Yen, and Y.Y. Shen Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomasa preliminary report J Cancer Res Clin Oncol 128 2002 503 506
65. S.A. Sohaib, G. Cook, and S.D. Allen Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer Br J Radiol 82 2009 632 639
66. E. Even-Sapir, U. Metser, and E. Mishani The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT J Nucl Med 47 2006 287 297
67. P. Bhargava, M. Hanif, and C. Nash Whole-body F-18 sodium fluoride PET-CT in a patient with renal cell carcinoma Clin Nucl Med 33 2008 894 895